hair loss with glp-1 loss: why it happens, what the research shows, and how to protect your hair How to tackle GLP-1 hair

Semaglutide therapy and reproductive outcomes: An emerging area of concern

Credit: J

Respondents had an average age of 42.6 years and were 54.4% female, 45.1% male, and 0.5% nonbinary, representing all 50 states and the District of Columbia

Instead of waiting until advanced disease stages or after other therapies fail, GLP-1s are increasingly being used early, sometimes even at diagnosis

This is an evolving area, and expert groups recommend individual risk assessment rather than blanket fear

The more options people have, the better, says Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine